NIH Director Statement on Catalyzing the Development of Novel Alternative Methods
This report, which the ACD enthusiastically endorsed and conveyed to the agency, recommended that NIH work with the community to:
Prioritize the development and use of combinatorial NAMs
Establish resources, infrastructure, and collaborations to promote the use of interoperable, reliable, and well curated/high quality datasets produced from research using NAMs
Promote effective dissemination and interconnection of NAM technologies
Invest in comprehensive training to bolster continuous advances in development and use of NAMs
Facilitate multidisciplinary teams with expertise across technologies and the lifecy...
Source: NIH Extramural Nexus - February 9, 2024 Category: Research Authors: Mike Lauer Tags: blog Open Mike Alternatives to Animals Animal Welfare rigor Source Type: funding
Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of Post-Acute Sequelae of SARS-CoV-2 Infection on Mission Specific Sensory and Communication Disorders
Notice NOT-DC-24-001 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 14, 2023 Category: Research Source Type: funding
Emergency Award: Novel Insights through Cross-Site Analyses of Existing RADx-UP Data (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-OD-23-050 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) will support analyses of existing RADx-UP data by proposing novel questions related to SARS-CoV-2 testing and health disparities. These projects will explore important questions focused on COVID-19 testing access and uptake, factors affecting testing and related COVID-19 outcomes, and meta-analyses of specific COVID-19 response and intervention approaches within and across populations. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 2, 2023 Category: Research Source Type: funding
New FY 2022 Categorical Spending Data Are Now Available
NIH recently updated its annual categorical information with fiscal year (FY) 2022 actual spending data and estimates for FY 2023 and 2024. Available on the Research, Condition, and Disease Categorization (RCDC) page, you will find the annual support level for various research, condition, and disease categories. The data are based on grants, contracts, and other funding mechanisms used across NIH.
There were 215 public categories when RCDC information began being reported in 2008. Now in our fifteenth year, there are a total of 315 categories. The following new categories were added in FY 2022:
Cocaine
PASC (Post-Acute Se...
Source: NIH Extramural Nexus - April 4, 2023 Category: Research Authors: NIH Staff Tags: New Resources NIH budget RCDC Source Type: funding
Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
Funding Opportunity RFA-NS-23-022 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to invite exploratory and innovative research applications focused on theneurological and neuropsychiatric manifestationsof COVID-19 (neuro-COVID) andPost-Acute Sequelae of SARS-CoV-2 Infection (neuro-PASC) and on the effect of COVID-19 on pre-infection neurologic conditions. Applications investigating the pathophysiology and mechanisms of neuro-COVID and neuro-PASC and neurologically-focused human subjects research, as well as those proposing studies of scientifically compelling pat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 28, 2023 Category: Research Source Type: funding
Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
Funding Opportunity RFA-NS-23-021 from the NIH Guide for Grants and Contracts. The purpose of thisNotice of Funding Opportunity (NOFO)is to invite applicationsfocused on theneurological and neuropsychiatric manifestationsof COVID-19 (neuro-COVID) andPost-Acute Sequelae of SARS-CoV-2 Infection (neuro-PASC) and on the effect of COVID-19 on pre-infection neurologic conditions. Applications investigating the pathophysiology and mechanisms of neuro-COVID and neuro-PASC and neurologically-focused human subjects research, as well as those proposing studies of scientifically compelling pathways to prevent the development of neu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 28, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)
Notice NOT-NS-23-068 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 23, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)
Notice NOT-NS-23-069 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 23, 2023 Category: Research Source Type: funding
Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DK-22-016 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement invites applications to conduct a study to establish a longitudinal cohort of individuals who developed diabetes following SARS-CoV-2 infection to understand the pathophysiology and clinical course post-COVID diabetes. The cohort must include children and adults and reflect the geography and demographics of COVID-19 in the U.S. There must be an appropriate comparator population recruited and followed. The goals are to determine the contribution of: 1) specific pathophysiologic pathways; 2) overall health ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 13, 2022 Category: Research Source Type: funding
Request for Information (RFI): Inviting comments to inform the National Institutes of Health (NIH) on the intersection of the SARS-CoV-2/COVID-19 pandemic and the health of women
Notice NOT-OD-22-092 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2022 Category: Research Source Type: funding
Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)
Funding Opportunity RFA-OD-22-006 from the NIH Guide for Grants and Contracts. The goals of this funding opportunity announcement (FOA) are to implement and rigorously evaluate SARS-CoV-2 rapid testing strategies in communities experiencing COVID-19 health disparities. These two-year Rapid Testing Research Projects will evaluate (1) rapid testing interventions to prevent and control COVID-19 transmission among underserved and vulnerable populations and (2) partnership-driven research to implement and evaluate rapid testing and reduce COVID-19 disparities. The funding for this program is provided from the American Rescue...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 17, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies
Notice NOT-GM-22-026 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 21, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research on Pathobiological Mechanisms of Post-Acute Sequelae of SARS-CoV-2 Infection
Notice NOT-OD-22-038 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 7, 2021 Category: Research Source Type: funding
Request for Information (RFI): Input on Technologies and Approaches that can Identify Individuals Susceptible to Developing Post-Acute-Sequelae of SARS-CoV-2 infection (PASC)
Notice NOT-HL-21-018 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 22, 2021 Category: Research Source Type: funding
Notice of Clarification of Responsiveness to NIAAA RFA-AA-21-004 "SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed)"
Notice NOT-AA-21-041 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 14, 2021 Category: Research Source Type: funding
